1 October 2015 in Journal of Pharmaceutical and Biomedical Analysis
1 April 2012 in Journal of Pharmaceutical Analysis
Three sensitive, selective and reproducible stability-indicating methods are presented for determination of nitazoxanide (NTZ), a new anti-protozoal drug, in presence of its degradation products. Method A utilizes the first derivative of ratio spectra spectrophotometry by measurement of the amplitude at 364.4 nm using one of the degradation products as a divisor. Method B is a chemometric-assisted spectrophotometry, where principal component regression (PCR) and partial least squares (PLS) were applied. These two approaches were successfully applied to quantify NTZ in presence of degradation products using the information included in the absorption spectra in the range 260-360 nm. Method C is based on the separation of NTZ from its degradation products followed by densitometric measurement of the bands at 254 nm. The separation was carried out on silica gel 60F254, using chloroform-methanol-ammonia solution-glacial acetic acid (95:5:1:1 by volume, pH=5.80) as a developing system. These methods are suitable as stability-indicating methods for the determination of NTZ in presence of its degradation products either in bulk powder or in pharmaceutical formulations. Statistical analysis of the results has been carried out revealing high accuracy and good precision.
30 December 2011 in Biomedical Chromatography
1 May 2017 in Arabian Journal of Chemistry
RP-HPLC chromatographic method was developed for the determination of hyoscine N-butyl bromide (HBB) and Paracetamol (PAR). In this chromatographic method, HBB and PAR were separated using C18 (25cm×4.6mm i.d. 5μm particle size) column as a stationary phase and water: methanol (50:50, V/V pH adjusted to 3.9 with CF3COOH acid) as a mobile phase, maintaining the flow rate at 1.0mLmin−1 with UV detection at 210nm. The proposed method was successfully applied for the determination of HBB and PAR in pure form over a concentration range of 2.0–50.0μgmL−1 for HBB with mean percentage recovery of 100.10±0.475 and over a concentration range of 5.0–200.0μgmL−1 for PAR with mean percentage recovery of 99.87±0.942 and in their pharmaceutical formulations (Buscopan plus® tablets, Buscamol® tablets and Buscopan plus® suppositories)
1 June 2012 in Acta Pharmaceutica
Simultaneous determination of methocarbamol and ibuprofen or diclofenac potassium using mean centering of the ratio spectra method Accurate and sensitive methods were developed for simultaneous determination of methocarbamol and ibuprofen or diclofenac potassium in their binary mixtures, and in the presence of a methocarbamol related substance (guaifenesin) using mean centering of the ratio spectra method. The results obtained were statistically compared with the reported HPLC methods; no significant difference between the proposed methods and the reported methods was found regarding either accuracy or precision.
1 November 2014 in Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy